510(k) Report

510(k) · Cleared

Cleared

Clave™ Neutral-Displacement Needlefree Connectors

K250616510(k) TraditionalCleared Jun 5, 202597-day reviewClass II21 CFR 880.5440

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Icu Medical, Inc. · FPA Set, Administration, Intravascular

Cleared on Jun 5, 2025 as substantially equivalent to K100434 (Icu Medical, Inc., 2010) after a 97-day review. Its family tree reaches back 5 generations to 1995.

Decided
Jun 5, 2025
Review
97 days
Class
Class II
Product code
FPA
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K942988 (1995). 8 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 5 generations backK942988 Filtered Extension SetsB. Braun of America, Inc. · 1995 · Recalled
  2. 4 generations backK955585 V2 Injection SiteB.Braun Medical, Inc. · 1996 · Recalled
  3. 3 generations backK973167 Positive Pressure ConnectorIcu Medical, Inc. · 1997
  4. 2 generations backK021692 CLC2000 Catheter Patency DeviceIcu Medical, Inc. · 2003
  5. 1 generation backK100434 Clave NeutronIcu Medical, Inc. · 2010 · Recalled
  6. This deviceK250616 Clave™ Neutral-Displacement Needlefree ConnectorsIcu Medical, Inc. · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K942988Filtered Extension SetsB. Braun of America, Inc.199532
−4K955585V2 Injection SiteB.Braun Medical, Inc.199627
−3K973167Positive Pressure ConnectorIcu Medical, Inc.1997—
−2K021692CLC2000 Catheter Patency DeviceIcu Medical, Inc.2003—
−1K100434Clave NeutronIcu Medical, Inc.20103
0 (this device)K250616Clave™ Neutral-Displacement Needlefree ConnectorsIcu Medical, Inc.2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710
200310
200910
FIG. 1 — Lineage of K250616, 1995–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FPA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FPA device

  1. #1 K243841 Sparta Infusion Set for Insulinscore 13.4 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K100434Clave Neutron
Summary page 5
…Panel General Hospital Product Code(s) FPA Legally marketed device(s) to Predicate: ClaveTM Neutron K100434 which equivalence is claimed Trade or proprietary name Clave ™ Neutron Common or usual name…
Icu Medical, Inc.20103
†K212842Microvolume Luer Access DeviceB.Braun Medical, Inc.2022—

Also cleared against K100434: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 30 years and passes through 3 companies; a new generation was cleared every 6.0 years on median.
  • 5 of the 8 ancestors have a recall of any class.
  • 1 other device also cites its predicate K100434.

How does its category compare?

All FPA devices

FPA Set, Administration, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · FPA

11in 2025

2007: 162008: 182009: 102010: 232011: 122012: 212013: 132014: 222015: 172016: 122017: 172018: 42019: 72020: 102021: 132022: 142023: 142024: 72025: 112026 (partial year): 5
2007high 23 (2010) · low 4 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FPA

225in 2025

2007: 75 days median2008: 89 days median2009: 166 days median2010: 120 days median2011: 87 days median2012: 96 days median2013: 90 days median2014: 89 days median2015: 123 days median2016: 195 days median2017: 240 days median2018: 177 days median2019: 161 days median2020: 327 days median2021: 186 days median2022: 213 days median2023: 340 days median2024: 244 days median2025: 225 days median2026 (partial year): 266 days median
2007high 340 (2023) · low 75 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FPA

98in 2025

2007: 172008: 152009: 1662010: 582011: 282012: 16, 4 Class I2013: 642014: 242015: 62016: 102017: 132018: 42019: 132020: 1072021: 12022: 9, 5 Class I2023: 12, 4 Class I2024: 13, 1 Class I2025: 98, 1 Class I2026 (partial year): 10, 2 Class I
2007high 166 (2009) · low 1 (2021)2026

Class I (17 since 2007) Class II/III not classified

Adverse event reports per year · FPA

34,506in 2025

2007: 1,4992008: 1,9412009: 2,5122010: 2,5372011: 4,4072012: 4,9302013: 4,6512014: 4,6952015: 6,6252016: 8,4702017: 6,4622018: 6,5742019: 11,2272020: 9,5632021: 10,4142022: 13,3932023: 10,9162024: 47,2102025: 34,506
2007high 47,210 (2024) · low 1,499 (2007)2025

MAUDE reports naming product code FPA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071675171,499
20081889151,941
2009101661662,512
201023120582,537
20111287284,407
2012219616 (4)4,930
20131390644,651
20142289244,695
20151712366,625
201612195108,470
201717240136,462
2018417746,574
201971611311,227
2020103271079,563
202113186110,414
2022142139 (5)13,393
20231434012 (4)10,916
2024724413 (1)47,210
20251122598 (1)34,506
2026526610 (2)—

What is it indicated for?

Clave Neutral-Displacement Connectors (MicroClave ™/ NanoClave ™/ Clave ™Neutron) are intended for the aspiration, injection, or gravity/pump flow of IV fluids and blood upon insertion of a male luer connector. Clave Connectors may be used with power injectors at a maximum pressure of 400 psi and a maximum flow rate of 10ml/sec. Clave Connectors will prevent microbial ingress for seven (7) days.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K250616: Clave™ Neutral-Displacement Needlefree Connectors.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K250616

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026